Since angiogenesis has an indispensable effect in the development and progression of
tumors, in this study we aimed to identify angiogenic genes closely associated with …

Hepatocyte growth factor (HGF), through activation of the c-MET receptor, mediates
biological processes critical for tissue regeneration; however, its clinical application is …

Vasohibin-1 has recently been found and is known as an endogenous angiogenesis
inhibitor, but the role of vasohibin-1 in hepatocellular carcinoma (HCC) is unknown. This …

Aim: Application of immunotherapy to a patient with untreatable hepatocellular carcinoma.
Case Report: The patient had a tumor of 60 mm in the liver. The pathological anatomic …

Hepatocellular carcinoma (HCC) is one of the major causes of cancer‑related mortality
worldwide, with the majority of cases associated with persistent hepatitis B virus (HBV) or …

MATERIALS AND METHODS We undertook literature searches in June 2010 to identify
English publications solely focused on comparisons of outcomes of LDLT and DDLT for …

Objective: To assess whether photobiomodulation therapy (PBMT) induces angiogenesis in
diabetic mice with hindlimb ischemia (HLI). Background: Patients with diabetes mellitus …

Background The VEGF gene polymorphism rs699947 related to clinical pathology, mortality,
and recurrence of HCC. Few studies mentioned an association between VEGF gene …

Background Dovitinib is a receptor tyrosine kinase (RTK) inhibitor targeting vascular
endothelial growth factor receptors, fibroblast growth factor receptors and platelet-derived …

Purpose Human hepatocellular carcinoma (HCC) has unique vascular features, which
require selective imaging of hepatic arterial perfusion and portal venous perfusion with …